Calendar TransCode Therapeutics, Inc.

Equities

RNAZ

US89357L3033

Real-time Estimate Cboe BZX 14:52:50 29/04/2024 BST 5-day change 1st Jan Change
0.547 USD -0.53% Intraday chart for TransCode Therapeutics, Inc. +18.58% -91.74%

Chart calendar TransCode Therapeutics, Inc.

b5afab1.5i92E5SVCRvpoIXk_KPbgQNaZgKJNmiS7H19ZdUs-G4.uUwZddX7MUii5tadkJDoxEYKB2DxUxna2jc-H5lgkjS_HUZBpORWa6jBvQ~f927e3d9af87467934aafe046b6b4081

Upcoming events on TransCode Therapeutics, Inc.

12/05/2024 Q1 2024 Earnings Release (Projected)
11/08/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
27/03/2025 Q4 2024 Earnings Release (Projected)

Past events on TransCode Therapeutics, Inc.

03/04/2024 14:10 Q4 2023 Earnings Release
14/03/2024 13:10 RNA Leaders Europe Congress
08/01/2024 14:00 Extraordinary Shareholders Meeting
04/12/2023 San Antonio Breast Cancer Symposium
14/11/2023 21:30 Q3 2023 Earnings Release
19/10/2023 18:30 ThinkEquity Conference
11/09/2023 H.C. Wainwright Global Investment Conference
14/08/2023 21:45 Q2 2023 Earnings Release
09/05/2023 Annual General Meeting
13/04/2023 American Association for Cancer Research Meeting
31/03/2023 21:01 Q4 2022 Earnings Release
14/11/2022 21:15 Q3 2022 Earnings Release
09/11/2022 19:30 Sidoti Micro Cap Virtual Conference
26/10/2022 19:30 ThinkEquity Conference
03/10/2022 18:00 Chardan Genetic Medicines Conference
15/08/2022 21:15 Interim 2022 Earnings Release
22/06/2022 16:00 Annual General Meeting
13/06/2022 22:30 BIO International Convention
24/05/2022 12:00 H.C. Wainwright Global Life Sciences Investment Conference
16/05/2022 13:30 Q1 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-6,15
-6,07
-1.42%
-18,7
-18,7
0.18%
-19,4
-21,1
7.97%

-14,7

Earnings before Tax (EBT)
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

Net income
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EPS
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

Announcement Date31/03/2231/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-



0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-2,99
-2,90
-2.97%
-4,71
-3,90
-20.7%
-4,95
-5,30
6.54%
-5,53
-5,60
1.3%



-5,13
-5,10
-0.6%
-5,33
-5,60
4.87%
-4,06
-5,70
28.79%

-3,20


-3,40


-3,80


-4,30

Net income
Million USD
Released
Forecast
Spread












-4,82























EPS
USD
Released
Forecast
Spread












-264























Announcement Date31/03/2215/08/2214/11/2231/03/2315/05/2314/08/2314/11/2301/04/24----

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

  1. Stock Market
  2. Equities
  3. RNAZ Stock
  4. Calendar TransCode Therapeutics, Inc.